Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
11 drugs in development
By Therapeutic Area
top 6
R&D Momentum
88/100
Pipeline Velocity
64/100
Trial Completion Rate
70/100
Pipeline Concentration
24/100
Pipeline Freshness
79/100
Strategic Signals
Activity
Last 14 days
Taurine Supplementation as a Novel Therapeutic Approach for Neurocognitive Symptoms in Long COVID
Use of Passive Myofunctional Appliances for Snoring and Mild Obstructive Sleep Apnea
Effects of the Serotonin Precursor, 5-hydroxytryptophan, in the Injured Human Spinal Cord
Long-term Follow-up of Infant Frenotomy/Frenectomy Through Early Childhood
Feasibility, Efficacy And Safety Of De Novo Extended-Release Tacrolimus Following Liver Transplantation
Treatment of Pediatric Hypertrophic Tonsils and Pediatric Obstructive Sleep Apnea by Non-invasive Photobiomodulation
Can Brief Exposure to Hyperoxia Improve Function After Chronic Spinal Cord Injury?
Outpatient Preoperative Parenteral Nutrition in Malnourished Surgical Patients: A Feasibility Study
Reducing Inpatient Readmission Rates for Patients Discharged From Acute Psychiatric Care in Alberta Using Peer and Text Message Support: Protocol for an Innovative Supportive Program
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)